➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Johnson and Johnson
Moodys
Express Scripts
Colorcon

Last Updated: January 26, 2021

DrugPatentWatch Database Preview

Litigation Details for Horizon Medicines LLC v. Alkem Laboratories Ltd. (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Horizon Medicines LLC v. Alkem Laboratories Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Horizon Medicines LLC v. Alkem Laboratories Ltd. (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-07-09 1 Complaint United States Patent Nos. 8,067,033 (“the ’033 patent”), 8,067,451 (“the ’451 patent”), 8,309,127 (“…910 and ’228 patents. COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,067,033 33…one or more claims of U.S. Patent No. 8,067,033; B. A judgment declaring the…(“the ’127 patent”), 8,318,202 (“the ’202 patent”), 8,449,910 (“the ’910 patent”), and 8,501,228 (“the…. This is an action for patent infringement arising under the patent laws of the United States, External link to document
2020-08-07 187 Opinion - Memorandum Opinion infringement of U.S. Patent No. 8,067,033 (“the ’033 patent”) and the ’451 patent. (D.I. 1). Following…construction of one term in U.S. Patent No. 8,067,451 (“the ’451 patent”). The Court has considered the…construction issues concerning the ’033 patent. (D.I. 89.) The ’451 patent is addressed to methods and oral… “It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2020-08-28 200 Letter streamlining issues at trial re: infringement of U.S. Patent 8,067,451. (Stover, Chad) (Entered: 08/28/2020) …2018 30 November 2020 1:18-cv-01014 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2020-09-26 218 Post Trial Brief Post-Trial Brief Regarding Invalidity of U.S. Patent No. 8,067,033, by Alkem Laboratories Ltd.. (Attachments…2018 30 November 2020 1:18-cv-01014 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2020-09-30 221 Redacted Document POST Trial Brief Regarding Invalidity of Patent No. 8,067,033 by Alkem Laboratories Ltd.. (Gattuso, Dominick…2018 30 November 2020 1:18-cv-01014 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2020-11-29 238 Opinion parties had narrowed the case to U.S. Patent No. 8,067,033 (“the ’033 patent”). 3 Before the Court…Unenforceability and/or Non-Infringement for U.S. Patent Nos. 8,067,033 B2, 8,067,451 B2, 8,309,127 B2, 8,318,202…infringement of U.S. Patent Nos. 8,309,127 (the “’127 patent”), 8,318,202 (the “’202 patent”), 8,449,910 (the…the ’033 patent, and the ’096 publication is only a patent publication, not a granted patent.” (Id.).…asserted patent claims. Horizon asserts infringement of claims 1, 8, 11, and 14 of the ’033 patent. (D.I External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Boehringer Ingelheim
McKesson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.